Alkyne–azide cycloaddition analogues of dehydrozingerone as potential anti-prostate cancer inhibitors <i>via</i> the PI3K/Akt/NF-kB pathway

Chetan Kumar, Reyaz ur Rasool, Zainab Iqra, Yedukondalu Nalli, Prabhu Dutt, Naresh K. Satti, Neha Sharma, Sumit G. Gandhi, Anindya Goswami, Asif Ali

MedChemComm · 2017 · 22 citations · 25 references

DOIFull text

Open access

Concepts

Abstract

Alkyne–azide cycloaddition derivatives of DHZ (<bold>1</bold>) were synthesized and screened for cytotoxic potential in which the derivatives, <bold>3</bold>, <bold>6</bold>, <bold>7</bold>, <bold>8</bold>, <bold>9</bold> and <bold>15</bold> displayed most potent with IC<sub>50</sub> value ranging from 1.8–3.0 μM.

References

25